Methscopolamine Bromide Tablet
Product Images NDC 72319-030

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methscopolamine Bromide (NDC 72319-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methscopolamine-i3-2-5mg-100 (Methscopolamine I3 2 5mg 100)

This text describes a medication containing 2.5 mg of Methscopolamine Bromide for oral administration. The tablets also list inactive ingredients and storage instructions. The product information provided mentions FDA approval and distribution details by i3 Pharmaceuticals, LLC. It is crucial to consult the package insert for recommended adult dosage and complete information.*

FDA Label Image

Methscopolamine-i3-2-5mg-1000 (Methscopolamine I3 2 5mg 1000)

This text describes a medication containing 2.5 mg of Methscopolamine Bromide in tablet form for oral administration. It provides details on the usual adult dosage, impurity specifications, inactive ingredients (including microcrystalline cellulose and magnesium stearate), and storage instructions. The medication does not contain lactose and should be dispensed in a light-resistant container. The product is distributed by i3 Pharmaceuticals, LLC in Pennsylvania, USA. The tablets are made in the USA and come in a package of 1000 tablets. The information also includes the NDC code for the product.*

FDA Label Image

Methscopolamine-i3-5mg-1000 (Methscopolamine I3 5mg 1000)

This text provides information about Methscopolamine Bromide tablets containing 5mg of the active ingredient. It lists the usual adult dosage, FDA-approved impurity specifications, inactive ingredients, and storage instructions. The tablets do not contain lactose and should be dispensed in a tight, light-resistant container. The product is distributed by i3 Pharmaceuticals, LLC in the USA. The package includes 1000 tablets and the NDC number is 72319-030-06. The tablets are for oral administration only.*

FDA Label Image

Methscopolamine-i3-5mg-60 (Methscopolamine I3 5mg 60)

The text describes a tablet containing 5 mg of Methscopolamine Bromide, USP, with details such as dosage, inactive ingredients, and storage instructions. The tablet does not contain lactose. It should be dispensed in a light-resistant container and stored at 20° to 25°C. The product is distributed by i3 Pharmaceuticals, LLC in Warminster, PA. No detailed product information is available.*

FDA Label Image

Methscopolamine-structure (Methscopolamine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.